» Articles » PMID: 30745901

Conservation, Extensive Heterozygosity, and Convergence of Signaling Potential All Indicate a Critical Role for KIR3DL3 in Higher Primates

Abstract

Natural killer (NK) cell functions are modulated by polymorphic killer cell immunoglobulin-like receptors (KIR). Among 13 human genes, which vary by presence and copy number, is ubiquitously present in every individual across diverse populations. No ligand or function is known for KIR3DL3, but limited knowledge of expression suggests involvement in reproduction, likely during placentation. With 157 human alleles, KIR3DL3 is also highly polymorphic and we show heterozygosity exceeds that of HLA-B in many populations. The external domains of catarrhine primate KIR3DL3 evolved as a conserved lineage distinct from other KIR. Accordingly, and in contrast to other KIR, we show the focus of natural selection does not correspond exclusively to known ligand binding sites. Instead, a strong signal for diversifying selection occurs in the D1 Ig domain at a site involved in receptor aggregation, which we show is polymorphic in humans worldwide, suggesting differential ability for receptor aggregation. Meanwhile in the cytoplasmic tail, the first of two inhibitory tyrosine motifs (ITIM) is conserved, whereas independent genomic events have mutated the second ITIM of KIR3DL3 alleles in all great apes. Together, these findings suggest that KIR3DL3 binds a conserved ligand, and a function requiring both receptor aggregation and inhibitory signal attenuation. In this model KIR3DL3 resembles other NK cell inhibitory receptors having only one ITIM, which interact with bivalent downstream signaling proteins through dimerization. Due to the extensive conservation across species, selection, and other unusual properties, we consider elucidating the ligand and function of to be a pressing question.

Citing Articles

Expression of NKp46 and other activating inhibitory receptors on uterine endometrial NK cells in females with various reproductive failures: A review.

Mai C, Fukui A, Saeki S, Takeyama R, Yamaya A, Shibahara H Reprod Med Biol. 2025; 24(1):e12610.

PMID: 39807425 PMC: 11725765. DOI: 10.1002/rmb2.12610.


Analysis of KIR and HLA Polymorphism in Chinese Individuals With COVID-19.

Tao S, You X, Norman P, Kichula K, Dong L, Chen N HLA. 2024; 104(4):e15715.

PMID: 39364548 PMC: 11458138. DOI: 10.1111/tan.15715.


Prognostic model incorporating immune checkpoint genes to predict the immunotherapy efficacy for lung adenocarcinoma: a cohort study integrating machine learning algorithms.

Yang X, Zeng Z, Wang C, Wang G, Zhang F Immunol Res. 2024; 72(4):851-863.

PMID: 38755433 DOI: 10.1007/s12026-024-09492-7.


The repertoire of a West African chimpanzee population is characterized by limited gene, allele, and haplotype variation.

de Groot N, Heijmans C, van der Wiel M, Bruijnesteijn J, Bontrop R Front Immunol. 2023; 14:1308316.

PMID: 38149259 PMC: 10750417. DOI: 10.3389/fimmu.2023.1308316.


Exceptional diversity of KIR and HLA class I in Egypt.

Montero-Martin G, Kichula K, Misra M, Vargas L, Marin W, Hollenbach J HLA. 2023; 103(1):e15177.

PMID: 37528739 PMC: 11068459. DOI: 10.1111/tan.15177.


References
1.
Kruse P, Rosner C, Walter L . Characterization of rhesus macaque KIR genotypes and haplotypes. Immunogenetics. 2010; 62(5):281-93. DOI: 10.1007/s00251-010-0433-4. View

2.
Li H, Wright P, McCullen M, Anderson S . Characterization of KIR intermediate promoters reveals four promoter types associated with distinct expression patterns of KIR subtypes. Genes Immun. 2015; 17(1):66-74. PMC: 4724278. DOI: 10.1038/gene.2015.56. View

3.
Lanier L . Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol. 2008; 9(5):495-502. PMC: 2669298. DOI: 10.1038/ni1581. View

4.
Long E, Barber D, Burshtyn D, Faure M, Peterson M, Rajagopalan S . Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158). Immunol Rev. 2001; 181:223-33. DOI: 10.1034/j.1600-065x.2001.1810119.x. View

5.
Fan Q, Long E, Wiley D . Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol. 2001; 2(5):452-60. DOI: 10.1038/87766. View